{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:52:55Z","timestamp":1791665575038,"version":"4.3.4"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"am","delay-in-days":317,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21K08077"],"award-info":[{"award-number":["JP21K08077"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP24K11236"],"award-info":[{"award-number":["JP24K11236"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ejphar.2025.177355","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T19:33:57Z","timestamp":1738870437000},"page":"177355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Sodium-glucose cotransporter 2 inhibitor empagliflozin enhances autophagy and reverses remodeling in hearts with large, old myocardial infarctions"],"prefix":"10.1016","volume":"992","author":[{"given":"Susumu","family":"Endo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7705-715X","authenticated-orcid":false,"given":"Hiromitsu","family":"Kanamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genki","family":"Naruse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Komura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Minatoguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takatomo","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Mikami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuhiko","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhiko","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Okura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.177355_bib1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cardiores.2004.04.014","article-title":"Inhibition of the Na+\/H+ exchanger attenuates the deterioration of ventricular function during pacing-induced heart failure in rabbits","volume":"63","author":"Aker","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2025.177355_bib2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2337\/dc19-1410","article-title":"Reinterpreting cardiorenal protection of renal sodium-glucose cotransporter 2 inhibitors via cellular life history programming","volume":"43","author":"Avogaro","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2025.177355_bib3","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s00125-016-4134-x","article-title":"Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+\/H+ exchanger in rats and rabbits","volume":"60","author":"Baartscheer","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2025.177355_bib4","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1056\/NEJMoa2314051","article-title":"Empagliflozin after acute myocardial infarction","volume":"390","author":"Butler","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2025.177355_bib5","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1093\/cvr\/cvaa323","article-title":"Off-target effects of sodium-glucose co-transporter 2 blockers: empagliflozin does not inhibit Na+\/H+ exchanger-1 or lower [Na+]i in the heart","volume":"117","author":"Chung","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2025.177355_bib6","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s00125-007-0628-x","article-title":"Enhanced activity of the myocardial Na+\/H+ exchanger contributes to left ventricular hypertrophy in the Goto-Kakizaki rat model of type 2 diabetes: critical role of Akt","volume":"50","author":"Darmellah","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2025.177355_bib7","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijcard.2017.05.032","article-title":"Sodium-dependent glucose transporters (SGLT) in human ischemic heart: a new potential pharmacological target","volume":"243","author":"Di Franco","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ejphar.2025.177355_bib8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00059-022-05157-z","article-title":"European guidelines on heart failure: pharmacotherapy","volume":"48","author":"Grundmann","year":"2023","journal-title":"Herz"},{"key":"10.1016\/j.ejphar.2025.177355_bib9","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: A report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2025.177355_bib10","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0092-8674(03)00929-2","article-title":"TSC2 mediates cellular energy response to control cell growth and survival","volume":"115","author":"Inoki","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2025.177355_bib11","doi-asserted-by":"crossref","first-page":"322","DOI":"10.4161\/auto.5603","article-title":"A method to measure cardiac autophagic flux in vivo","volume":"4","author":"Iwai-Kanai","year":"2008","journal-title":"Autophagy"},{"key":"10.1016\/j.ejphar.2025.177355_bib12","doi-asserted-by":"crossref","first-page":"H2544","DOI":"10.1152\/ajpheart.00338.2002","article-title":"Influence of gender on the response to hemodynamic overload after myocardial infarction","volume":"283","author":"Jain","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2025.177355_bib13","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s13238-020-00809-4","article-title":"Cardioprotective mechanism of SGLT2 inhibitor against myocardial infarction is through reduction of autosis","volume":"13","author":"Jiang","year":"2022","journal-title":"Protein Cell"},{"key":"10.1016\/j.ejphar.2025.177355_bib14","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1093\/emboj\/19.21.5720","article-title":"LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing","volume":"19","author":"Kabeya","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.ejphar.2025.177355_bib15","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.2353\/ajpath.2009.080875","article-title":"Functional significance and morphological characterization of starvation-induced autophagy in the adult heart","volume":"174","author":"Kanamori","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2025.177355_bib16","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/cvr\/cvr073","article-title":"The role of autophagy emerging in postinfarction cardiac remodeling","volume":"91","author":"Kanamori","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2025.177355_bib17","doi-asserted-by":"crossref","first-page":"H2261","DOI":"10.1152\/ajpheart.01056.2010","article-title":"Autophagy limits acute myocardial infarction induced by permanent coronary artery occlusion","volume":"300","author":"Kanamori","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2025.177355_bib18","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ajpath.2012.11.009","article-title":"Resveratrol reverses remodeling in hearts with large, old myocardial infarctions through enhanced autophagy-activating AMP kinase pathway","volume":"182","author":"Kanamori","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2025.177355_bib19","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005418","article-title":"Metformin enhances autophagy and provides cardioprotection in \u03b4-sarcoglycan deficiency-induced dilated cardiomyopathy","volume":"12","author":"Kanamori","year":"2019","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ejphar.2025.177355_bib20","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jacc.2021.11.059","article-title":"Impact of autophagy on prognosis of patients with dilated cardiomyopathy","volume":"79","author":"Kanamori","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2025.177355_bib21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41556-018-0244-7","article-title":"The lysosome as a cellular centre for signalling, metabolism and quality control","volume":"21","author":"Lawrence","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejphar.2025.177355_bib22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cell.2007.12.018","article-title":"Autophagy in the pathogenesis of disease","volume":"132","author":"Levine","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2025.177355_bib23","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.4161\/auto.25560","article-title":"The variability of autophagy and cell death susceptibility: unanswered questions","volume":"9","author":"Loos","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.ejphar.2025.177355_bib24","first-page":"632","article-title":"Mechanisms of cardiovascular benefits of sodium glucose Co-transporter 2 (SGLT2) inhibitors: a state-of-the-art review","volume":"5","author":"Lopaschuk","year":"2020","journal-title":"J. Am. Coll. Cardiol. Basic Trans. Science."},{"key":"10.1016\/j.ejphar.2025.177355_bib25","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1161\/CIRCULATIONAHA.117.030012","article-title":"Cherney DZI. Sodium glucose cotransporter-2 inhibition in heart failure: potential mechanisms, clinical applications, and summary of clinical trials","volume":"136","author":"Lytvyn","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2025.177355_bib26","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2025.177355_bib27","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.athoracsur.2007.10.054","article-title":"Sodium-hydrogen exchange inhibition by cariporide to reduce the risk of ischemic cardiac events in patients undergoing coronary artery bypass grafting: results of the EXPEDITION study","volume":"85","author":"Mentzer","year":"2008","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.ejphar.2025.177355_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172810","article-title":"Empagliflozin restores lowered exercise endurance capacity via the activation of skeletal muscle fatty acid oxidation in a murine model of heart failure","volume":"866","author":"Nambu","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177355_bib29","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123130","article-title":"SGLT2 inhibition reprograms systemic metabolism via FGF21-dependent and -independent mechanisms","volume":"4","author":"Osataphan","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.ejphar.2025.177355_bib30","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2025.177355_bib31","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2337\/dci19-0074","article-title":"SGLT2 inhibitors produce cardiorenal benefits by promoting adaptive cellular reprogramming to induce a state of fasting mimicry: a paradigm shift in understanding their mechanism of action","volume":"43","author":"Packer","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2025.177355_bib32","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007197","article-title":"Cardioprotective effects of sirtuin-1 and its downstream effectors: potential role in mediating the heart failure benefits of SGLT2 (Sodium-Glucose cotransporter 2) inhibitors","volume":"13","author":"Packer","year":"2020","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ejphar.2025.177355_bib33","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/01.RES.77.6.1192","article-title":"pHi regulation in myocardium of the spontaneously hypertensive rat. Compensated enhanced activity of the Na(+)-H+ exchanger","volume":"77","author":"P\u00e9rez","year":"1995","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2025.177355_bib34","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1146\/annurev.med.46.1.455","article-title":"Left ventricular remodeling after acute myocardial infarction","volume":"46","author":"Pfeffer","year":"1995","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ejphar.2025.177355_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.00021.2015","article-title":"Mechanistic pathways of sex differences in cardiovascular disease","volume":"97","author":"Regitz-Zagrosek","year":"2017","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2025.177355_bib36","doi-asserted-by":"crossref","first-page":"13G","DOI":"10.1016\/0002-9149(93)90102-I","article-title":"Reperfusion in acute myocardial infarction: effect of timing and modulating factors in experimental models","volume":"72","author":"Reimer","year":"1993","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejphar.2025.177355_bib37","article-title":"Sodium-glucose CoTransporter-2 inhibitor empagliflozin ameliorates sunitinib-induced cardiac dysfunction via regulation of AMPK-mTOR signaling pathway-mediated autophagy","volume":"12","author":"Ren","year":"2012","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177355_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173420","article-title":"Anti-hypertrophic effect of Na+\/H+ exchanger-1 inhibition is mediated by reduced cathepsin B","volume":"888","author":"Riaz","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177355_bib39","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1161\/CIRCULATIONAHA.118.038881","article-title":"Possible mechanism of hematocrit elevation by sodium glucose cotransporter 2 inhibitors and associated beneficial renal and cardiovascular effects","volume":"139","author":"Sano","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2025.177355_bib40","doi-asserted-by":"crossref","first-page":"8689","DOI":"10.1038\/s41598-023-35944-5","article-title":"Empagliflozin reduces arrhythmogenic effects in rat neonatal and human iPSC-derived cardiomyocytes and improves cytosolic calcium handling at least partially independent of NHE1","volume":"13","author":"Silva","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.177355_bib41","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000191","article-title":"Cathepsin-L ameliorates cardiac hypertrophy through activation of the autophagy-lysosomal dependent protein processing pathways","volume":"2","author":"Sun","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ejphar.2025.177355_bib42","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.jacc.2024.03.405","article-title":"Left ventricular function, congestion, and effect of empagliflozin on heart failure risk after myocardial infarction","volume":"83","author":"Udell","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2025.177355_bib43","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s00125-017-4509-7","article-title":"Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na+\/H+ exchanger, lowering of cytosolic Na+ and vasodilation","volume":"61","author":"Uthman","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2025.177355_bib44","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/cvr\/cvz004","article-title":"Delayed ischaemic contracture onset by empagliflozin associates with NHE1 inhibition and is dependent on insulin in isolated mouse hearts","volume":"115","author":"Uthman","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2025.177355_bib45","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.yjmcc.2013.02.007","article-title":"Regulation of the cardiac Na\u207a\/H\u207a exchanger in health and disease","volume":"61","author":"Wakabayashi","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2025.177355_bib46","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1161\/01.RES.79.1.79","article-title":"Developmental changes in the delayed rectifier K+ channels in mouse heart","volume":"79","author":"Wang","year":"1996","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2025.177355_bib47","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.ajpath.2014.01.011","article-title":"Restriction of food intake prevents postinfarction heart failure by enhancing autophagy in the surviving cardiomyocytes","volume":"184","author":"Watanabe","year":"2014","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2025.177355_bib48","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0735-1097(00)00730-0","article-title":"Sarcolemmal Na+\/H+ exchanger activity and expression in human ventricular myocardium","volume":"36","author":"Yokoyama","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2025.177355_bib49","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cardfail.2019.02.009","article-title":"(Pro)renin receptor blockade ameliorates heart failure caused by chronic kidney disease","volume":"25","author":"Yoshida","year":"2019","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ejphar.2025.177355_bib50","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/ejhf.1473","article-title":"Sodium-glucose co-transporter 2 inhibition with empagliflozin improves cardiac function in non-diabetic rats with left ventricular dysfunction after myocardial infarction","volume":"21","author":"Yurista","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ejphar.2025.177355_bib51","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/S0735-1097(01)01608-4","article-title":"The Na(+)\/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial","volume":"38","author":"Zeymer","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2025.177355_bib52","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/jcb.10631","article-title":"Human cardiomyocytes express high level of Na+\/glucose cotransporter 1 (SGLT1)","volume":"90","author":"Zhou","year":"2009","journal-title":"J. Cell. Biochem."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925001086?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925001086?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:27:25Z","timestamp":1762144045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925001086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":52,"alternative-id":["S0014299925001086"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177355","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sodium-glucose cotransporter 2 inhibitor empagliflozin enhances autophagy and reverses remodeling in hearts with large, old myocardial infarctions","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177355","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"177355"}}